全文获取类型
收费全文 | 27283篇 |
免费 | 2064篇 |
国内免费 | 83篇 |
专业分类
耳鼻咽喉 | 351篇 |
儿科学 | 795篇 |
妇产科学 | 547篇 |
基础医学 | 3527篇 |
口腔科学 | 354篇 |
临床医学 | 2665篇 |
内科学 | 6003篇 |
皮肤病学 | 405篇 |
神经病学 | 2575篇 |
特种医学 | 1146篇 |
外科学 | 4775篇 |
综合类 | 277篇 |
现状与发展 | 1篇 |
一般理论 | 51篇 |
预防医学 | 2006篇 |
眼科学 | 412篇 |
药学 | 1336篇 |
中国医学 | 37篇 |
肿瘤学 | 2167篇 |
出版年
2023年 | 308篇 |
2022年 | 544篇 |
2021年 | 1271篇 |
2020年 | 675篇 |
2019年 | 983篇 |
2018年 | 1183篇 |
2017年 | 816篇 |
2016年 | 788篇 |
2015年 | 958篇 |
2014年 | 1314篇 |
2013年 | 1587篇 |
2012年 | 2346篇 |
2011年 | 2284篇 |
2010年 | 1240篇 |
2009年 | 976篇 |
2008年 | 1511篇 |
2007年 | 1588篇 |
2006年 | 1383篇 |
2005年 | 1259篇 |
2004年 | 1075篇 |
2003年 | 906篇 |
2002年 | 772篇 |
2001年 | 183篇 |
2000年 | 154篇 |
1999年 | 180篇 |
1998年 | 161篇 |
1997年 | 134篇 |
1996年 | 143篇 |
1995年 | 115篇 |
1994年 | 84篇 |
1993年 | 89篇 |
1992年 | 120篇 |
1991年 | 120篇 |
1990年 | 117篇 |
1989年 | 126篇 |
1988年 | 103篇 |
1987年 | 108篇 |
1986年 | 97篇 |
1985年 | 98篇 |
1984年 | 107篇 |
1983年 | 88篇 |
1982年 | 102篇 |
1981年 | 80篇 |
1980年 | 69篇 |
1979年 | 86篇 |
1978年 | 87篇 |
1977年 | 49篇 |
1975年 | 44篇 |
1974年 | 46篇 |
1973年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
Robert A. Schnoll Ph.D. James Calvin B.A. Michael Malstrom B.S. Randi L. Rothman B.A. Hao Wang M.S. James Babb Ph.D. Suzanne M. Miller Ph.D. John A. Ridge M.D. Ph.D. Benjamin Movsas M.D. Corey Langer M.D. Michael Unger M.D. Melvyn Goldberg M.D. 《Annals of behavioral medicine》2003,25(3):214-221
Even though continued smoking by cancer patients adversely affects survival and quality of life, about one third of patients
who smoked prior to their diagnosis continue to smoke after their diagnosis. The implementation of smoking cessation treatments
for cancer patients has been slowed by the lack of data on correlates of tobacco use in this population. Thus, this longitudinal
study assessed demographic, medical, addiction, and psychological predictors of tobacco use among 74 head, neck, and lung
cancer patients. Multivariable binary logistic regression analyses, with outcome categorized as smoker or nonsmoker, indicated
that the likelihoodthat patients would be a smoker was associated with lower levels of perceived risk and a higher level of
quitting cons. Multivariable nominal logistic regression, with outcome classified as continuous smoker, continuous quitter,
relapser, or follow-up quitter, indicated that: (a) patients categorized as continuous smokers reported significantly lower
quitting self-efficacy than follow-up quitters and continuous quitters, (b) relapsers reported a significantly lower level
of quitting self-efficacy than either follow-up quitters or continuous quitters, and (c) continuous smokers exhibited a significantly
lower level of risk perceptions than continuous abstainers. These findings can be useful for the development and evaluation
of treatments to promote smoking cessation among cancer patients.
Support for this study was provided by National Institutes of Health Grants CA57708, CA06927, CA88610, CA95678, and CA76644. 相似文献
52.
One of the advantages of polyurethane foam-covered prostheses has been that in the first 5 to 10 years after their use, the
amount of capsular contraction was found much less than when similar ``slick' prostheses were used. Another advance was their
fixation to the surrounding tissue thus giving a more natural appearance and movement with the muscles when the arms were
moved in any direction. The formation of a thick capsule also acted as a protection against gel granuloma due to rupture of
the prosthesis and has been thought to be a factor in the lower capsule contraction rate. The greatest disadvantage has been
that its removal was extremely difficult and this has continued up until the technique described in this paper has been introduced. 相似文献
53.
54.
A system for assaying homologous recombination at the endogenous human thymidine kinase gene.
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
M B Benjamin H Potter D W Yandell J B Little 《Proceedings of the National Academy of Sciences of the United States of America》1991,88(15):6652-6656
A system for assaying human interchromosomal recombination in vitro was developed, using a cell line containing two different mutant thymidine kinase genes (TK) on chromosomes 17. Heteroalleles were generated in the TK+/+ parent B-lymphoblast cell line WIL-2 by repeated exposure to the alkylating nitrogen mustard ICR-191, which preferentially causes +1 or -1 frameshifts. Resulting TK-/- mutants were selected in medium containing the toxic thymidine analog trifluorothymidine. Mutations were characterized by exon-specific polymerase chain reaction amplification and direct sequencing. In two lines, heterozygous frameshifts were located in exons 4 and 7 of the TK gene separated by approximately 8 kilobases. These lines undergo spontaneous reversion to TK+ at a frequency of less than 10(-7), and revertants can be selected in cytidine/hypoxanthine/aminopterin/thymidine medium. The nature and location of these heteroallelic mutations make large deletions, rearrangements, nondisjunction, and reduplication unlikely mechanisms for reversion to TK+. The mode of reversion to TK+ was specifically assessed by DNA sequencing, use of single-strand conformation polymorphisms, and analysis of various restriction fragment length polymorphisms (RFLPs) linked to the TK gene on chromosome 17. Our data suggest that a proportion of revertants has undergone recombination and gene conversion at the TK locus, with concomitant loss of frameshifts and allele loss at linked RFLPs. Models are presented for the origin of two recombinants. 相似文献
55.
Arthroscopic shoulder surgery has become a safe tool for evaluation and treatment of a wide range of shoulder problems with few complications. With ever-improving technology (and commitment to motor skill development among arthroscopists), we can expect to maintain this low rate despite increasing procedure complexity. Avoiding complications in arthroscopic shoulder surgery requires careful preoperative planning, judicious patient selection, a thorough understanding of arthroscopic anatomy, and facility with arthroscopic techniques. 相似文献
56.
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials.
Vincent Meininger Gilbert Bensimon Walter R Bradley Benjamin Brooks Patrice Douillet Andrew A Eisen Lucette Lacomblez P Nigel Leigh Wim Robberecht 《Amyotrophic lateral sclerosis and other motor neuron disorders》2004,5(2):107-117
Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive and fatal motor neuron disease. We carried out two randomized, double-blind, placebo-controlled, multi-centre, multi-national studies with xaliproden (a drug with neurotrophic effect) to assess drug efficacy and safety at two doses. Patients with clinically probable or definite ALS of more than 6 months and less than 5 years duration were randomly assigned to placebo, 1 mg or 2 mg xaliproden orally once daily as monotherapy in Study 1 (n=867); or to the same regimen with addition of riluzole 50 mg bid background therapy in Study 2 (n=1210 patients). The two primary endpoints were defined as: 1. Time to death, tracheostomy, or permanent assisted ventilation (DTP), and 2. Time to vital capacity (VC)<50% or DTP before (log-rank test) and after adjustment using a Cox proportional hazard model for prespecified prognostic factors. Secondary endpoints were rates of change of various functional measures. In Study 1, primary outcome measures did not reach statistical significance. For the 2 mg group, for time to VC<50% analysis (without DTP) a significant 30% RRR was obtained (95% confidence interval [CI]: 8.46, P=0.009). In Study 2, no significant results were obtained. However, there was a trend in favour of add-on 1 mg dose xaliproden vs. placebo (RRR 15% [-6.31, ns] for time to VC<50%; RRR 12% [CI: -6.27, ns] for time to VC<50% or DTP). Adjusted RR ratios were consistently more favourable for the xaliproden groups. Tolerability was good, and dose-dependent side effects were largely associated with the serotonergic properties of xaliproden. An effect of xaliproden on functional parameters, especially VC, was noted. Although this effect did not reach statistical significance, xaliproden had a small effect on clinically noteworthy aspects of disease progression in ALS. 相似文献
57.
L S Benjamin 《Dental clinics of North America》1992,36(1):77-93; discussion 94-5
The subperiosteal implant has long been regarded as the most successful, predictable, and versatile of all implant systems. In some cases, however, anatomic morphology and surgical technique present certain limitations for the subperiosteal procedure. Through CAD/CAM multiplanar diagnostic imaging, not only have we been able to eliminate the first stage of the surgical procedure, but we have expanded the capabilities and versatility of the subperiosteal procedure. In addition, coating the subperiosteal implant frame with hydroxyapatite has allowed the achievement of bony union, thus increasing the long-range prognosis of the individual case. 相似文献
58.
59.
Shlomo Kyzer M.D. Benjamin Mitmaker M.D. Ph.D. F.R.C.S. Philip H. Gordon M.D. F.R.C.S. F.A.C.S. Hyman Schipper M.D. Ph.D. F.R.C.P. Eugenia Wang Ph.D. 《Diseases of the colon and rectum》1992,35(9):879-883
The field change is one hypothesis concerning the development of colorectal carcinoma. Removal of a carcinoma without its entire surrounding altered mucosa may result in the development of a recurrence. S44, a monoclonal antibody directed against statin, a nuclear protein expressed in nonproliferating cells in either a quiescent or senescent state, was used to determine the rate of cell growth in colorectal mucosa at different distances from carcinomas. The specimens of 18 patients undergoing resection of a colorectal carcinoma were immediately opened after operation, and strips of mucosa were taken at distances of 1 cm, 5 cm, and 10 cm from the carcinoma. For each location, 10 longitudinally oriented crypts were evaluated for statin-positive cells identified by the presence of a dark brown peroxidase-conjugated antibody reaction product. The average percentage of statin-positive cells per crypt was significantly lower at a 1-cm distance from the carcinoma compared with the mucosa located 5 and 10 cm from the carcinoma (20.89±4.33 at 1 cm, 32.41±5.27 at 5 cm, and 34.23±6.45 at 10 cm). None of the calculated parameters showed any significant difference between the 5-cm and 10-cm locations. The fact that the proliferation rate of the mucosal cells returns to the normal level at 5 cm from the margin of the carcinoma suggests that cells located within this distance still retain proliferative potential even though they are morphologically indistinguishable from their normal counterparts. We conclude that failure to remove this transitional, potentially proliferative mucosa may result in subsequent development of anastomotic or perianastomotic recurrences.This study was conducted with support from the Sir Mortimer B. Davis-Jewish General Hospital Foundation and the American Physician Fellowship and with grants to Eugenia Wang from the Medical Research Council of Canada and from the National Institute on Aging of the National Institutes of Health of the U.S.A. 相似文献
60.
D E Fleischer F al-Kawas S Benjamin J H Lewis J Kidwell 《Gastrointestinal endoscopy》1992,38(4):411-414
In 1989, the American Society for Gastrointestinal Endoscopy released a quality assurance monograph in which a procedure review process was outlined. The major elements of the program for quality assurance in gastrointestinal endoscopy included: (1) procedure reports, (2) an endoscopic unit record, and (3) a procedure review. This study was designed to use the procedure review process to determine the incidence of complications, to identify quality assurance issues, and to determine whether audits and/or studies would result from this process. To make a meaningful interpretation as to what constitutes an important complication, a classification to define potential problems was established. Using this classification, a complication was identified in 64 of 3287 procedures (1.9%). These complications were discussed in a monthly morbidity and mortality conference. Additionally, 21 quality assurance issues were identified that led to four studies addressing these quality assurance issues. 相似文献